サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1386418

静脈疾患治療市場レポート：2030年までの動向、予測、競合分析

Venous Diseases Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

静脈疾患治療市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

静脈疾患治療の動向と予測

世界の静脈疾患治療市場は、2024年から2030年までのCAGRが6.5%で、2030年までに推定91億米ドルに達すると予測されます。この市場の主な促進要因は、静脈疾患の罹患率の増加、静脈疾患に対する意識の高まり、ヘルスケア支出の増加です。世界の静脈疾患治療市場は、硬化療法、ラジオ波焼灼療法、レーザー治療、外来静脈瘤切除術、静脈結紮・剥離術、血管形成術またはステント留置術、手術、圧迫療法、静脈作用薬、大静脈フィルター市場にビジネスチャンスがあり、将来性が期待されます。

静脈疾患治療市場の洞察

Lucintelは、静脈瘤症例の増加と静脈瘤治療のための低侵襲的処置により、静脈瘤が最大セグメントであり続けると予測しています。

この市場の中では、レーザー治療が予測期間中に最も高い成長を示すと予想されます。これは、静脈疾患を治療するために、より少ない治療時間で最小限の侵襲的な手順に対する需要の高まりと、現在進行中の技術開発によるものです。

北米は、米国人口の静脈瘤疾患の増加、高齢化人口の大幅な増加、診断と治療の技術的進歩により、最大の地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の静脈疾患治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の静脈疾患治療市場の動向（2018～2023年）と予測（2024～2030年）
  • 製品タイプ別の世界の静脈疾患治療市場
    • 硬化療法注射
    • アブレーション装置
    • 静脈閉鎖製品
    • 静脈ステント
    • 薬剤
    • その他
  • 疾患タイプ別の世界の静脈疾患治療市場
    • 深部静脈血栓症
    • 慢性静脈不全
    • 肺塞栓症
    • 表在性血栓性静脈炎
    • 静脈瘤
    • その他
  • 治療タイプ別の世界の静脈疾患治療市場
    • 硬化療法
    • 高周波アブレーション療法
    • レーザー治療
    • 外来静脈切除術
    • 静脈結紮とストリッピング
    • 血管形成術またはステント留置術
    • 手術
    • 圧迫療法
    • その他
  • 最終用途別の世界の静脈疾患治療市場
    • 病院
    • クリニック
    • 外来手術センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の静脈疾患治療市場
  • 北米の静脈疾患治療市場
  • 欧州の静脈疾患治療市場
  • アジア太平洋静脈疾患治療市場
  • その他地域静脈疾患治療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界の静脈疾患治療市場の成長機会
    • 疾患タイプ別の世界の静脈疾患治療市場の成長機会
    • 治療タイプ別の世界の静脈疾患治療市場の成長機会
    • 最終用途別の世界の静脈疾患治療市場の成長機会
    • 地域別の世界の静脈疾患治療市場の成長機会
  • 世界の静脈疾患治療市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の静脈疾患治療市場の能力拡大
    • 世界の静脈疾患治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Abbott
  • Imricor
  • Medtronic
  • Stryker
  • Koninklijke Philips
  • Baylis Medical
  • Theraclion
  • Sonablate
  • Boston Scientific
  • Olympus
目次

Venous Diseases Treatment Trends and Forecast

The future of the global venous diseases treatment market looks promising with opportunities in the sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, venoactive medication, and vena cava filter markets. The global venous diseases treatment market is expected to reach an estimated $9.1 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing incidences of venous diseases, growing awareness towards venous disorders, and rising healthcare expenditure.

A more than 150-page report is developed to help in your business decisions.

Venous Diseases Treatment by Segment

The study includes a forecast for the global venous diseases treatment by product type, disease type, treatment type, end use, and region.

Venous Diseases Treatment Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sclerotherapy Injection
  • Ablation Devices
  • Venous Closure Products
  • Venous Stents
  • Medication
  • Others

Venous Diseases Treatment Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Deep Vein Thrombosis
  • Chronic Venous Insufficiency
  • Pulmonary Embolism
  • Superficial Thrombophlebitis
  • Varicose Veins
  • Others

Venous Diseases Treatment Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sclerotherapy
  • Radiofrequency Ablation Therapy
  • Laser Treatment
  • Ambulatory Phlebectomy
  • Vein Ligation & Stripping
  • Angioplasty Or Stenting
  • Surgeries
  • Compression Therapy
  • Others

Venous Diseases Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Venous Diseases Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Venous Diseases Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies venous diseases treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the venous diseases treatment companies profiled in this report include-

  • Abbott
  • Imricor
  • Medtronic
  • Stryker
  • Koninklijke Philips
  • Baylis Medical
  • Theraclion
  • Sonablate
  • Boston Scientific
  • Olympus

Venous Diseases Treatment Market Insights

Lucintel forecasts that varicose veins will remain the largest segment due to the increasing cases of varicose veins and minimally invasive procedures to treat varicose veins.

Within this market, laser treatment is expected to witness highest growth over the forecast period due to rising demand for minimal invasive procedure with less cure time and om-going technological development to treat venous diseases.

North America will remain the largest region due to growing number of varicose veins diseases among the US population, significantly growing aging population, and technological advancement of diagnosis and treatment in the region.

Features of the Global Venous Diseases Treatment Market

Market Size Estimates: Venous diseases treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Venous diseases treatment market size by various segments, such as by product type, disease type, treatment type, end use, and region in terms of ($B).

Regional Analysis: Venous diseases treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, disease types, treatment types, end uses, and regions for the venous diseases treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the venous diseases treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the venous diseases treatment market size?

Answer: The global venous diseases treatment market is expected to reach an estimated $9.1 billion by 2030.

Q.2 What is the growth forecast for venous diseases treatment market?

Answer: The global venous diseases treatment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the venous diseases treatment market?

Answer: The major drivers for this market are increasing incidences of venous diseases, growing awareness towards venous disorders, and rising healthcare expenditure.

Q4. What are the major segments for venous diseases treatment market?

Answer: The future of the venous diseases treatment market looks promising with opportunities in the sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, venoactive medication, and vena cava filter markets.

Q5. Who are the key venous diseases treatment market companies?

Answer: Some of the key venous diseases treatment companies are as follows:

  • Abbott
  • Imricor
  • Medtronic
  • Stryker
  • Koninklijke Philips
  • Baylis Medical
  • Theraclion
  • Sonablate
  • Boston Scientific
  • Olympus

Q6. Which venous diseases treatment market segment will be the largest in future?

Answer: Lucintel forecasts that varicose veins will remain the largest segment due to the increasing cases of varicose veins and minimally invasive procedures to treat varicose veins.

Q7. In venous diseases treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing number of varicose veins diseases among the US population, significantly growing aging population, and technological advancement of diagnosis and treatment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the venous diseases treatment market by product type (sclerotherapy injection, ablation devices, venous closure products, venous stents, medication, and others), disease type (deep vein thrombosis, chronic venous insufficiency, pulmonary embolism, superficial thrombophlebitis, varicose veins, and others), treatment type (sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, and others), end use (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Venous Diseases Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Venous Diseases Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Venous Diseases Treatment Market by Product Type
    • 3.3.1: Sclerotherapy Injection
    • 3.3.2: Ablation Devices
    • 3.3.3: Venous Closure Products
    • 3.3.4: Venous Stents
    • 3.3.5: Medication
    • 3.3.6: Others
  • 3.4: Global Venous Diseases Treatment Market by Disease Type
    • 3.4.1: Deep Vein Thrombosis
    • 3.4.2: Chronic Venous Insufficiency
    • 3.4.3: Pulmonary Embolism
    • 3.4.4: Superficial Thrombophlebitis
    • 3.4.5: Varicose Veins
    • 3.4.6: Others
  • 3.5: Global Venous Diseases Treatment Market by Treatment Type
    • 3.5.1: Sclerotherapy
    • 3.5.2: Radiofrequency ablation therapy
    • 3.5.3: Laser Treatment
    • 3.5.4: Ambulatory Phlebectomy
    • 3.5.5: Vein Ligation & stripping
    • 3.5.6: Angioplasty or Stenting
    • 3.5.7: Surgeries
    • 3.5.8: Compression Therapy
    • 3.5.9: Others
  • 3.6: Global Venous Diseases Treatment Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Clinics
    • 3.6.3: Ambulatory Surgical Centers
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Venous Diseases Treatment Market by Region
  • 4.2: North American Venous Diseases Treatment Market
    • 4.2.1: North American Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.2.2: North American Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others
  • 4.3: European Venous Diseases Treatment Market
    • 4.3.1: European Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.3.2: European Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others
  • 4.4: APAC Venous Diseases Treatment Market
    • 4.4.1: APAC Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.4.2: APAC Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others
  • 4.5: ROW Venous Diseases Treatment Market
    • 4.5.1: ROW Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.5.2: ROW Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Venous Diseases Treatment Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Venous Diseases Treatment Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Venous Diseases Treatment Market by Treatment Type
    • 6.1.4: Growth Opportunities for the Global Venous Diseases Treatment Market by End Use
    • 6.1.5: Growth Opportunities for the Global Venous Diseases Treatment Market by Region
  • 6.2: Emerging Trends in the Global Venous Diseases Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Venous Diseases Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Venous Diseases Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Imricor
  • 7.3: Medtronic
  • 7.4: Stryker
  • 7.5: Koninklijke Philips
  • 7.6: Baylis Medical
  • 7.7: Theraclion
  • 7.8: Sonablate
  • 7.9: Boston Scientific
  • 7.10: Olympus